Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

NCT00755274 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Orthomyxoviridae Infections

Interventions

BIOLOGICAL: Influenza Virus Vaccine No Preservative: Pediatric Dose
BIOLOGICAL: Influenza Virus Vaccine No Preservative: Pediatric Dose

Sponsor

Sanofi Pasteur, a Sanofi Company